cd564

CD564 is a synthetic small molecule belonging to the class of organic compounds known as benzophenones. Its chemical structure is defined as "6-(5,5,8,8-tetramethyl‑5‑‑‑‑‑‑⁄⁄⁄⁄⁄⁄tetrahydronaphthalene‑2‑carbonyl)naphthalene‑2-carboxylic acid." CD564 has been identified in virtual drug screening studies as a high-affinity ligand targeting the BRF2-TBP binding interface on the BRF2 protein. This suggests potential utility in modulating BRF2 function and possibly inhibiting cancer cell growth by interfering with transcriptional regulation pathways involving BRF2[1][2][5]. However—beyond computational and preclinical findings—there are no reports of clinical use or approval.

Other names

6-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carbonyl)naphthalene-2-carboxylic acid6-(5,5,8,8-tetramethyl–6,7-dihydronaphthalene–2-carbonyl)naphthalene–2-carboxylic acid6-[1,2,3,4-Tetrahydro–1,1,4,4-tetramethylnaphthalene)-6–ylcarbonyl]-2-naphthalenecarboxylic acid6-(5,5,8 ,8-TETRAMETHYL–5 ,6 ,7 ,8-TETRAHYDRO-NAPHTALENE–2-CARBONYL)-NAPHTALENE–2-CARBOXYLIC ACID1fcy6-(5 ,6 ,7 ,8-tetrahydro–5 ,5 ,8 ,8-tetramethyl–2-naphthoyl) -2-naphthoic acid6-[ (5 ,5 ,8 ,8-tetramethyl – 5 ,6 ,7 ,